NB
NeuroScientific Biopharmaceuticals Limited Stock: price and insider trades · Australia
NeuroScientific Biopharmaceuticals Limited: what insiders have been doing
Insider filings for NeuroScientific Biopharmaceuticals Limited are scarce in the ASX feed. This page will fill in as new trades are disclosed. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.06
Analyst consensus
1 analystsA$0.43Target A$0.43(+572%)A$0.43
Income statement
EBITDA-A$1.8M
Net income-A$1.8M0.0% margin
Valuation
P/Book1.3x
Beta1.12
Balance sheet & cash
Market capA$24.9M
Free Cash Flow-A$941.3k
Profitability & ownership
ROE-29.6%
ROA-19.4%
% insiders34.1%
% institutions0.0%
Declarations0 total
No declarations found
0 of 0 declarations
About NeuroScientific Biopharmaceuticals Limited
NSB is a company listed on the XASX, specializing in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
